|
|||||
|
|
Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas |
|
| Authors: | Yoon Sam S Duda Dan G Karl Daniel L Kim Tae-Min Kambadakone Avinash R Chen Yen-Lin Rothrock Courtney Rosenberg Andrew E Nielsen G Petur Kirsch David G Choy Edwin Harmon David C Hornicek Francis J Dreyfuss Jonathan Ancukiewicz Marek Sahani Dushyant V Park Peter J Jain Rakesh K Delaney Thomas F |
| Affiliation: | ∗ Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA † Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA § Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA ¶ Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA # Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA ∗∗ Department of Orthopedic Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA ‡ Center for Biomedical Informatics, Harvard Medical School and Partners Center for Personalized Genetic Medicine, Boston, MA ‖ Departments of Radiation Oncology and Cancer Biology, Duke University Medical Center, Durham, NC †† Department of Cancer Biology, University of Pennsylvania School of Medicine, Philadelphia, PA |
| Abstract: | |
| Keywords: | Sarcoma Angiogenesis inhibitors Radiotherapy Bevacizumab Biomarkers |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |